PHA-739358
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PHA-739358, covering 2013-12-18 to 2014-05-28. Get the full timeline:
Most recent: Clinical Trial Update: PHA-739358 for Treatment of Hormone Refractory Prostate Cancer [Phase 2]